Gene · 7001
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Knockdown of PRDX2 Inhibits the Proliferation, Growth, Migration, Invasion, and MMP9 Activity of Ewing's Sarcoma Cells Cultured In Vitro. | Cancer Rep (Hoboken) | 2024 | 39234629 | PubTator, text mining | PubMed |
| Influence of inhibiting methemoglobin formation on erythrocyte antioxidant defense. | Arch Biochem Biophys | 2024 | 39151873 | PubTator, text mining | PubMed |
| The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection. | AIDS | 2024 | 39007922 | PubTator, text mining | PubMed |
| Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers. | Biomed Pharmacother | 2024 | 38955087 | PubTator, text mining | PubMed |
| Catalase, Glutathione Peroxidase, and Peroxiredoxin 2 in Erythrocyte Cytosol and Membrane in Hereditary Spherocytosis, Sickle Cell Disease, and β-Thalassemia. | Antioxidants (Basel) | 2024 | 38929068 | PubTator, text mining | PubMed |
| Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease. | Eur J Med Chem | 2024 | 38925015 | PubTator, text mining | PubMed |
| The Impact of Acute EBV Infection on Changes in the Serum Proteome in Children-A Pilot Study. | Pathogens | 2024 | 38921769 | PubTator, text mining | PubMed |
| Activation of the ROS/TXNIP/NLRP3 pathway disrupts insulin-dependent glucose uptake in skeletal muscle of insulin-resistant obese mice. | Free Radic Biol Med | 2024 | 38897422 | PubTator, text mining | PubMed |
| Comparative proteomic analyses to investigate premature browning in high‑oxygen modified atmosphere packaged beef patties. | Food Chem | 2024 | 38876067 | PubTator, text mining | PubMed |
| Author Correction: SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma. | Sci Rep | 2024 | 38862588 | PubTator, text mining | PubMed |
| Effect of 3D and 2D cell culture systems on trophoblast extracellular vesicle physico-chemical characteristics and potency. | Front Cell Dev Biol | 2024 | 38835509 | PubTator, text mining | PubMed |
| Echinatin suppresses cutaneous squamous cell carcinoma by targeting GSTM3-mediated ferroptosis. | Phytomedicine | 2024 | 38833947 | PubTator, text mining | PubMed |
| HPLC with chiral stationary phase for separation and kinetics study of aspartic acid epimerization in Peroxiredoxin 2 active site peptide. | J Pharm Biomed Anal | 2024 | 38815521 | PubTator, text mining | PubMed |
| Peroxiredoxin 2 as a potential prognostic biomarker associated with angiogenesis in cervical squamous cell cancer. | Oncol Lett | 2024 | 38807674 | PubTator, text mining | PubMed |
| Modeling Melanoma Heterogeneity In Vitro: Redox, Resistance and Pigmentation Profiles. | Antioxidants (Basel) | 2024 | 38790661 | PubTator, text mining | PubMed |
| Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells. | J Med Chem | 2024 | 38679872 | PubTator, text mining | PubMed |
| Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes. | Diabetes Care | 2024 | 38623619 | PubTator, text mining | PubMed |
| Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis. | Front Neurol | 2024 | 38585359 | PubTator, text mining | PubMed |
| Data independent acquisition reveals in-depth serum proteome changes in uremic pruritus. | Front Physiol | 2024 | 38577622 | PubTator, text mining | PubMed |
| Orosomucoid 2 as a biomarker of carotid artery atherosclerosis plaque vulnerability through its generation of reactive oxygen species and lipid accumulation in vascular smooth muscle cells. | Biochem Biophys Res Commun | 2024 | 38447392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7001/papers?page=8